Commentary on: Validation of sentinel lymph node dissection in prostate cancer: Experience in more than 2,000 patients

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 9, 2009, Pages 1375-1376

  Brenot Rossi, Isabelle ^a   Bastide, Cyrille ^b  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

COMPUTER ASSISTED TOMOGRAPHY; FALSE NEGATIVE RESULT; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; NOTE; PROSTATE CANCER; SENTINEL LYMPH NODE; VALIDATION PROCESS;

FALSE NEGATIVE REACTIONS; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; PROSTATIC NEOPLASMS;

EID: 68949201529     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1191-0     Document Type: Note

References (6)

1. Holl G, Dorn R, Wengenmair H, Weckermann D, Sciuk J. Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients. Eur J Nucl Med Mol Imaging 2009. doi: 10.1007/s00259-009-1157-2.
2. Heidenreich A (chairman), Bolla M, Joniau S, van der Kwast TH, Matveev V, Mason MD et al. European Association of Urology 2009. Guidelines on prostate cancer 2009.
3. I Brenot-Rossi D Rossi B Esterni S Brunelle G Chuto C Bastide 2008 Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure Eur J Nucl Med Mol Imaging 35 32 38
4. C Bastide I Brenot-Rossi S Garcia D Rossi 2009 Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100 cases Eur J Surg Oncol 35 751 756
5. MS Cookson NE Fleshner SM Soloway WR Fair 1997 Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications J Urol 157 559 562
6. K Touijer F Rabbani JR Otero FP Secin JA Eastham PT Scardino, et al 2007 Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1% J Urol 178 120 124